We flew from Vienna, Austria, to Paris two days before Christmas. I’ve always wanted to spend Christmas in Paris, and the year our daughter, Clementine, died, I decided it was time. I wasn’t ...

Gossamer Bio GOSS will release its quarterly earnings report on Thursday, 2025-05-15. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Gossamer Bio to report an ...

SAN DIEGO - Gossamer Bio, Inc. (NASDAQ:GOSS) saw its shares climb 5.4% after the biopharmaceutical company reported better-than-expected fourth quarter results and provided updates on its ...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...

Gossamer Bio develops Seralutinib, which is basically an inhaled TKI that targets vascular remodeling, inflammation, and fibrosis. This makes it ideal for treating PAH and PH-ILD. GOSS has so far ...

The former Charlie’s Inn southeast of La Crosse and the former Big Old Red Shed in Westby both have new names and relatively new owners, and Gossamer Wings has a new shop in downtown La Crosse.

The Gossamer Gear Whisper is one of the most impossible-looking tents I’ve ever seen. It’s a veritable palace for one person that packs up to the size of an oversized nalgene. There is also something ...

Gossamer Bio (GOSS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Cheri Haug, who opened Gossamer Wings Bead Store in 2002 in Jackson Plaza, said it will open an annex that will feature unique jewelry sold by a cooperative of local beading artists. Gossamer ...

The Dow Jones index closed higher by over 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and ...

Gossamer Bio and Chiesi Farmaceutici (the Chiesi Group) have announced a worldwide partnership and licence agreement to develop and market seralutinib for pulmonary hypertension. The partnership ...